Skip to main content
Top
Published in: BMC Nephrology 1/2024

Open Access 01-12-2024 | Arteriovenous Fistula | Research

Global variations in funding and use of hemodialysis accesses: an international report using the ISN Global Kidney Health Atlas

Authors: Anukul Ghimire, Samveg Shah, Utkarsh Chauhan, Kwaifa Salihu Ibrahim, Kailash Jindal, Rumeyza Kazancioglu, Valerie A. Luyckx, Jennifer M. MacRae, Timothy O. Olanrewaju, Robert R. Quinn, Pietro Ravani, Nikhil Shah, Stephanie Thompson, Somkanya Tungsanga, Tushar Vachharanjani, Silvia Arruebo, Fergus J. Caskey, Sandrine Damster, Jo-Ann Donner, Vivekanand Jha, Adeera Levin, Charu Malik, Masaomi Nangaku, Syed Saad, Marcello Tonelli, Feng Ye, Ikechi G. Okpechi, Aminu K. Bello, David W. Johnson

Published in: BMC Nephrology | Issue 1/2024

Login to get access

Abstract

Background

There is a lack of contemporary data describing global variations in vascular access for hemodialysis (HD). We used the third iteration of the International Society of Nephrology Global Kidney Health Atlas (ISN-GKHA) to highlight differences in funding and availability of hemodialysis accesses used for initiating HD across world regions.

Methods

Survey questions were directed at understanding the funding modules for obtaining vascular access and types of accesses used to initiate dialysis. An electronic survey was sent to national and regional key stakeholders affiliated with the ISN between June and September 2022. Countries that participated in the survey were categorized based on World Bank Income Classification (low-, lower-middle, upper-middle, and high-income) and by their regional affiliation with the ISN.

Results

Data on types of vascular access were available from 160 countries. Respondents from 35 countries (22% of surveyed countries) reported that > 50% of patients started HD with an arteriovenous fistula or graft (AVF or AVG). These rates were higher in Western Europe (n = 14; 64%), North & East Asia (n = 4; 67%), and among high-income countries (n = 24; 38%). The rates of > 50% of patients starting HD with a tunneled dialysis catheter were highest in North America & Caribbean region (n = 7; 58%) and lowest in South Asia and Newly Independent States and Russia (n = 0 in both regions). Respondents from 50% (n = 9) of low-income countries reported that > 75% of patients started HD using a temporary catheter, with the highest rates in Africa (n = 30; 75%) and Latin America (n = 14; 67%). Funding for the creation of vascular access was often through public funding and free at the point of delivery in high-income countries (n = 42; 67% for AVF/AVG, n = 44; 70% for central venous catheters). In low-income countries, private and out of pocket funding was reported as being more common (n = 8; 40% for AVF/AVG, n = 5; 25% for central venous catheters).

Conclusions

High income countries exhibit variation in the use of AVF/AVG and tunneled catheters. In low-income countries, there is a higher use of temporary dialysis catheters and private funding models for access creation.
Appendix
Available only for authorised users
Literature
1.
go back to reference Ravani P, Palmer SC, Oliver MJ, Quinn RR, MacRae JM, Tai DJ, et al. Associations between hemodialysis access type and clinical outcomes: a systematic review. J Am Soc Nephrol. 2013;24(3):465–73.CrossRefPubMedPubMedCentral Ravani P, Palmer SC, Oliver MJ, Quinn RR, MacRae JM, Tai DJ, et al. Associations between hemodialysis access type and clinical outcomes: a systematic review. J Am Soc Nephrol. 2013;24(3):465–73.CrossRefPubMedPubMedCentral
2.
go back to reference Ethier J, Mendelssohn DC, Elder SJ, Hasegawa T, Akizawa T, Akiba T, et al. Vascular access use and outcomes: an international perspective from the Dialysis outcomes and practice patterns study. Nephrol Dial Transpl. 2008;23(10):3219–26.CrossRef Ethier J, Mendelssohn DC, Elder SJ, Hasegawa T, Akizawa T, Akiba T, et al. Vascular access use and outcomes: an international perspective from the Dialysis outcomes and practice patterns study. Nephrol Dial Transpl. 2008;23(10):3219–26.CrossRef
3.
go back to reference Lok CE, Huber TS, Lee T, Shenoy S, Yevzlin AS, Abreo K, et al. KDOQI Clinical Practice Guideline for Vascular Access: 2019 update. Am J Kidney Dis. 2020;75(4):S1–164.CrossRefPubMed Lok CE, Huber TS, Lee T, Shenoy S, Yevzlin AS, Abreo K, et al. KDOQI Clinical Practice Guideline for Vascular Access: 2019 update. Am J Kidney Dis. 2020;75(4):S1–164.CrossRefPubMed
4.
go back to reference Chan CT, Blankestijn PJ, Dember LM, Gallieni M, Harris DCH, Lok CE et al. Dialysis initiation, modality choice, access, and prescription: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference. Kidney Int. 2019;96(1):37–47. Chan CT, Blankestijn PJ, Dember LM, Gallieni M, Harris DCH, Lok CE et al. Dialysis initiation, modality choice, access, and prescription: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference. Kidney Int. 2019;96(1):37–47.
5.
go back to reference Maguire IC, Browne LD, Dawood M, Leahy F, Ryan MC, White E, et al. Differential Impact of Central venous catheters versus Arteriovenous Fistulae on Quality of Life among Irish Haemodialysis patients. Kidney360. 2022;3(6):1065–72.CrossRefPubMedPubMedCentral Maguire IC, Browne LD, Dawood M, Leahy F, Ryan MC, White E, et al. Differential Impact of Central venous catheters versus Arteriovenous Fistulae on Quality of Life among Irish Haemodialysis patients. Kidney360. 2022;3(6):1065–72.CrossRefPubMedPubMedCentral
6.
go back to reference Quinn RR, Lamping DL, Lok CE, Meyer RA, Hiller JA, Lee J, et al. The Vascular Access Questionnaire: assessing patient-reported views of vascular access. J Vasc Access. 2008;9(2):122–8.CrossRefPubMed Quinn RR, Lamping DL, Lok CE, Meyer RA, Hiller JA, Lee J, et al. The Vascular Access Questionnaire: assessing patient-reported views of vascular access. J Vasc Access. 2008;9(2):122–8.CrossRefPubMed
8.
go back to reference Liyanage T, Ninomiya T, Jha V, Neal B, Patrice HM, Okpechi I, et al. Worldwide access to treatment for end-stage kidney disease: a systematic review. Lancet. 2015;385(9981):1975–82.CrossRefPubMed Liyanage T, Ninomiya T, Jha V, Neal B, Patrice HM, Okpechi I, et al. Worldwide access to treatment for end-stage kidney disease: a systematic review. Lancet. 2015;385(9981):1975–82.CrossRefPubMed
9.
go back to reference Htay H, Bello AK, Levin A, Lunney M, Osman MA, Ye F, et al. Hemodialysis Use and practice patterns: an International Survey Study. Am J Kidney Dis. 2021;77(3):326–e3351.CrossRefPubMed Htay H, Bello AK, Levin A, Lunney M, Osman MA, Ye F, et al. Hemodialysis Use and practice patterns: an International Survey Study. Am J Kidney Dis. 2021;77(3):326–e3351.CrossRefPubMed
10.
go back to reference Bello AK, Johnson DW, Feehally J, Harris D, Jindal K, Lunney M, et al. Global Kidney Health Atlas (GKHA): design and methods. Kidney Int Suppl (2011). 2017;7(2):145–53.CrossRefPubMed Bello AK, Johnson DW, Feehally J, Harris D, Jindal K, Lunney M, et al. Global Kidney Health Atlas (GKHA): design and methods. Kidney Int Suppl (2011). 2017;7(2):145–53.CrossRefPubMed
11.
go back to reference Bello AK, Okpechi IG, Jha V, Harris DCH, Levin A, Johnson DW. Understanding distribution and variability in care organization and services for the management of kidney care across world regions. Kidney Int Suppl (2011). 2021;11(2):e4–10.CrossRef Bello AK, Okpechi IG, Jha V, Harris DCH, Levin A, Johnson DW. Understanding distribution and variability in care organization and services for the management of kidney care across world regions. Kidney Int Suppl (2011). 2021;11(2):e4–10.CrossRef
12.
go back to reference Dębska-Ślizień A, Bello AK, Johnson DW, Jha V, Harris DCH, Levin A et al. International Society of Nephrology Global Kidney Health Atlas: structures, organization, and services for the management of kidney failure in Eastern and Central Europe. Kidney Int Suppl (2011). 2021;11(2):e24-e34. Dębska-Ślizień A, Bello AK, Johnson DW, Jha V, Harris DCH, Levin A et al. International Society of Nephrology Global Kidney Health Atlas: structures, organization, and services for the management of kidney failure in Eastern and Central Europe. Kidney Int Suppl (2011). 2021;11(2):e24-e34.
13.
go back to reference Riaz P, Caskey F, McIsaac M, Davids R, Htay H, Jha V, et al. Workforce capacity for the care of patients with kidney failure across world countries and regions. BMJ Glob Health. 2021;6(1):e004014.CrossRefPubMedPubMedCentral Riaz P, Caskey F, McIsaac M, Davids R, Htay H, Jha V, et al. Workforce capacity for the care of patients with kidney failure across world countries and regions. BMJ Glob Health. 2021;6(1):e004014.CrossRefPubMedPubMedCentral
14.
go back to reference Mudiayi D, Shojai S, Okpechi I, Christie EA, Wen K, Kamaleldin M, et al. Global Estimates of Capacity for Kidney Transplantation in World Countries and regions. Transplantation. 2022;106(6):1113–22.CrossRefPubMedPubMedCentral Mudiayi D, Shojai S, Okpechi I, Christie EA, Wen K, Kamaleldin M, et al. Global Estimates of Capacity for Kidney Transplantation in World Countries and regions. Transplantation. 2022;106(6):1113–22.CrossRefPubMedPubMedCentral
15.
go back to reference Lunney M, Bello AK, Levin A, Tam-Tham H, Thomas C, Osman MA, et al. Availability, accessibility, and quality of conservative kidney Management Worldwide. Clin J Am Soc Nephrol. 2020;16(1):79–87.CrossRefPubMedPubMedCentral Lunney M, Bello AK, Levin A, Tam-Tham H, Thomas C, Osman MA, et al. Availability, accessibility, and quality of conservative kidney Management Worldwide. Clin J Am Soc Nephrol. 2020;16(1):79–87.CrossRefPubMedPubMedCentral
16.
go back to reference Cho Y, Bello AK, Levin A, Lunney M, Osman MA, Ye F, et al. Peritoneal Dialysis use and practice patterns: an International Survey Study. Am J Kidney Dis. 2021;77(3):315–25.CrossRefPubMed Cho Y, Bello AK, Levin A, Lunney M, Osman MA, Ye F, et al. Peritoneal Dialysis use and practice patterns: an International Survey Study. Am J Kidney Dis. 2021;77(3):315–25.CrossRefPubMed
17.
go back to reference Wainstein M, Bello AK, Jha V, Harris DCH, Levin A, Gonzalez-Bedat MC et al. International Society of Nephrology Global Kidney Health Atlas: structures, organization, and services for the management of kidney failure in Latin America. Kidney Int Suppl (2011). 2021;11(2):e35-e46. Wainstein M, Bello AK, Jha V, Harris DCH, Levin A, Gonzalez-Bedat MC et al. International Society of Nephrology Global Kidney Health Atlas: structures, organization, and services for the management of kidney failure in Latin America. Kidney Int Suppl (2011). 2021;11(2):e35-e46.
18.
go back to reference Bello AK, McIsaac M, Okpechi IG, Johnson DW, Jha V, Harris DCH et al. International Society of Nephrology Global Kidney Health Atlas: structures, organization, and services for the management of kidney failure in North America and the Caribbean. Kidney Int Suppl (2011). 2021;11(2):e66-e76. Bello AK, McIsaac M, Okpechi IG, Johnson DW, Jha V, Harris DCH et al. International Society of Nephrology Global Kidney Health Atlas: structures, organization, and services for the management of kidney failure in North America and the Caribbean. Kidney Int Suppl (2011). 2021;11(2):e66-e76.
19.
go back to reference Oguejiofor F, Kiggundu DS, Bello AK, Swanepoel CR, Ashuntantang G, Jha V et al. International Society of Nephrology Global Kidney Health Atlas: structures, organization, and services for the management of kidney failure in Africa. Kidney Int Suppl (2011). 2021;11(2):e11-e23. Oguejiofor F, Kiggundu DS, Bello AK, Swanepoel CR, Ashuntantang G, Jha V et al. International Society of Nephrology Global Kidney Health Atlas: structures, organization, and services for the management of kidney failure in Africa. Kidney Int Suppl (2011). 2021;11(2):e11-e23.
20.
go back to reference Kelly DM, Anders HJ, Bello AK, Choukroun G, Coppo R, Dreyer G et al. International Society of Nephrology Global Kidney Health Atlas: structures, organization, and services for the management of kidney failure in Western Europe. Kidney Int Suppl (2011). 2021;11(2):e106-e118. Kelly DM, Anders HJ, Bello AK, Choukroun G, Coppo R, Dreyer G et al. International Society of Nephrology Global Kidney Health Atlas: structures, organization, and services for the management of kidney failure in Western Europe. Kidney Int Suppl (2011). 2021;11(2):e106-e118.
22.
go back to reference Lok CE, Allon M, Moist L, Oliver MJ, Shah H, Zimmerman D. Risk equation determining unsuccessful cannulation events and failure to maturation in arteriovenous fistulas (REDUCE FTM I). J Am Soc Nephrol. 2006;17(11):3204–12.CrossRefPubMed Lok CE, Allon M, Moist L, Oliver MJ, Shah H, Zimmerman D. Risk equation determining unsuccessful cannulation events and failure to maturation in arteriovenous fistulas (REDUCE FTM I). J Am Soc Nephrol. 2006;17(11):3204–12.CrossRefPubMed
23.
go back to reference Bikbov B, Bieber B, Andrusev A, Tomilina N, Zemchenkov A, Zhao J, et al. Hemodialysis practice patterns in the Russia Dialysis outcomes and practice patterns study (DOPPS), with international comparisons. Hemodial Int. 2017;21(3):393–408.CrossRefPubMed Bikbov B, Bieber B, Andrusev A, Tomilina N, Zemchenkov A, Zhao J, et al. Hemodialysis practice patterns in the Russia Dialysis outcomes and practice patterns study (DOPPS), with international comparisons. Hemodial Int. 2017;21(3):393–408.CrossRefPubMed
24.
go back to reference Zhao X, Niu Q, Gan L, Hou FF, Liang X, Ni Z, et al. Baseline data report of the China Dialysis Outcomes and practice patterns study (DOPPS). Sci Rep. 2021;11(1):873.CrossRefPubMedPubMedCentral Zhao X, Niu Q, Gan L, Hou FF, Liang X, Ni Z, et al. Baseline data report of the China Dialysis Outcomes and practice patterns study (DOPPS). Sci Rep. 2021;11(1):873.CrossRefPubMedPubMedCentral
25.
go back to reference Kitzler TM, Chun J. Understanding the current Landscape of kidney disease in Canada to Advance Precision Medicine guided Personalized Care. Can J Kidney Health Dis. 2023;10:20543581231154185.CrossRefPubMedPubMedCentral Kitzler TM, Chun J. Understanding the current Landscape of kidney disease in Canada to Advance Precision Medicine guided Personalized Care. Can J Kidney Health Dis. 2023;10:20543581231154185.CrossRefPubMedPubMedCentral
27.
go back to reference Wagner M, Ansell D, Kent DM, Griffith JL, Naimark D, Wanner C, et al. Predicting Mortality in Incident Dialysis patients: an analysis of the United Kingdom Renal Registry. Am J Kidney Dis. 2011;57(6):894–902.CrossRefPubMedPubMedCentral Wagner M, Ansell D, Kent DM, Griffith JL, Naimark D, Wanner C, et al. Predicting Mortality in Incident Dialysis patients: an analysis of the United Kingdom Renal Registry. Am J Kidney Dis. 2011;57(6):894–902.CrossRefPubMedPubMedCentral
28.
go back to reference Dumaine C, Kiaii M, Miller L, Moist L, Oliver MJ, Lok CE, et al. Vascular Access practice patterns in Canada: A National Survey. Can J Kidney Health Dis. 2018;5:2054358118759675.CrossRefPubMedPubMedCentral Dumaine C, Kiaii M, Miller L, Moist L, Oliver MJ, Lok CE, et al. Vascular Access practice patterns in Canada: A National Survey. Can J Kidney Health Dis. 2018;5:2054358118759675.CrossRefPubMedPubMedCentral
29.
go back to reference Graham J, Hiremath S, Magner PO, Knoll GA, Burns KD. Factors influencing the prevalence of central venous catheter use in a Canadian haemodialysis centre. Nephrol Dial Transpl. 2008;23(11):3585–91.CrossRef Graham J, Hiremath S, Magner PO, Knoll GA, Burns KD. Factors influencing the prevalence of central venous catheter use in a Canadian haemodialysis centre. Nephrol Dial Transpl. 2008;23(11):3585–91.CrossRef
31.
go back to reference Lok CE. Fistula first initiative: advantages and pitfalls. Clin J Am Soc Nephrol. 2007;2(5):1043–53.CrossRefPubMed Lok CE. Fistula first initiative: advantages and pitfalls. Clin J Am Soc Nephrol. 2007;2(5):1043–53.CrossRefPubMed
32.
go back to reference Pisoni RL, Zepel L, Port FK, Robinson BM. Trends in us vascular access use, patient preferences, and related practices: an update from the US DOPPS practice monitor with international comparisons. Am J Kidney Dis. 2015;65(6):905–15.CrossRefPubMed Pisoni RL, Zepel L, Port FK, Robinson BM. Trends in us vascular access use, patient preferences, and related practices: an update from the US DOPPS practice monitor with international comparisons. Am J Kidney Dis. 2015;65(6):905–15.CrossRefPubMed
33.
go back to reference Arhuidese IJ, Orandi BJ, Nejim B, Malas M, Francisco S. Utilization, patency, and complications associated with vascular access for hemodialysis in the United States. J Vasc Surg. 2018;68(4):1166–74.CrossRefPubMed Arhuidese IJ, Orandi BJ, Nejim B, Malas M, Francisco S. Utilization, patency, and complications associated with vascular access for hemodialysis in the United States. J Vasc Surg. 2018;68(4):1166–74.CrossRefPubMed
34.
go back to reference Malas MB, Canner JK, Hicks CW, Arhuidese IJ, Zarkowsky DS, Qazi U, et al. Trends in incident hemodialysis access and mortality. JAMA Surg. 2015;150(5):441–8.CrossRefPubMed Malas MB, Canner JK, Hicks CW, Arhuidese IJ, Zarkowsky DS, Qazi U, et al. Trends in incident hemodialysis access and mortality. JAMA Surg. 2015;150(5):441–8.CrossRefPubMed
35.
go back to reference Lee T. Fistula First Initiative: historical impact on Vascular Access practice patterns and influence on future vascular Access Care. Cardiovasc Eng Technol. 2017;8(3):244–54.CrossRefPubMedPubMedCentral Lee T. Fistula First Initiative: historical impact on Vascular Access practice patterns and influence on future vascular Access Care. Cardiovasc Eng Technol. 2017;8(3):244–54.CrossRefPubMedPubMedCentral
36.
go back to reference Brown RS, Patibandla BK, Goldfarb-Rumyantzev AS. The survival benefit of Fistula First, Catheter Last in hemodialysis is primarily due to patient factors. J Am Soc Nephrol. 2017;28(2):645–52.CrossRefPubMed Brown RS, Patibandla BK, Goldfarb-Rumyantzev AS. The survival benefit of Fistula First, Catheter Last in hemodialysis is primarily due to patient factors. J Am Soc Nephrol. 2017;28(2):645–52.CrossRefPubMed
37.
go back to reference Lomonte C, Basile C, Mitra S, Combe C, Covic A, Davenport A, et al. Should a fistula first policy be revisited in elderly haemodialysis patients? Nephrol Dial Transpl. 2019;34(10):1636–43.CrossRef Lomonte C, Basile C, Mitra S, Combe C, Covic A, Davenport A, et al. Should a fistula first policy be revisited in elderly haemodialysis patients? Nephrol Dial Transpl. 2019;34(10):1636–43.CrossRef
38.
go back to reference Zhang H, Lu H, Li W, Jiang G, Zou H. Expert consensus on the establishment and maintenance of native arteriovenous fistula. Chronic Dis Transl Med. 2021;7(4):235–53.PubMedPubMedCentral Zhang H, Lu H, Li W, Jiang G, Zou H. Expert consensus on the establishment and maintenance of native arteriovenous fistula. Chronic Dis Transl Med. 2021;7(4):235–53.PubMedPubMedCentral
40.
go back to reference Grant IR, Freercks RJ, Honiball EJ, Dube B. Analysis of the vascular access service for patients on haemodialysis in Livingstone Hospital. Cardiovasc J Afr. 2021;32(2):98–101.CrossRefPubMed Grant IR, Freercks RJ, Honiball EJ, Dube B. Analysis of the vascular access service for patients on haemodialysis in Livingstone Hospital. Cardiovasc J Afr. 2021;32(2):98–101.CrossRefPubMed
41.
42.
go back to reference Ramachandran R, Bhargava V, Jasuja S, Gallieni M, Jha V, Sahay M, et al. Interventional nephrology and vascular access practice: a perspective from South and Southeast Asia. J Vasc Access. 2022;23(6):849–60.CrossRefPubMed Ramachandran R, Bhargava V, Jasuja S, Gallieni M, Jha V, Sahay M, et al. Interventional nephrology and vascular access practice: a perspective from South and Southeast Asia. J Vasc Access. 2022;23(6):849–60.CrossRefPubMed
43.
go back to reference Alhassan SU, Adamu B, Abdu A, Aji SA. Outcome and complications of permanent hemodialysis vascular access in nigerians: a single centre experience. Ann Afr Med. 2013;12(2):127–30.CrossRefPubMed Alhassan SU, Adamu B, Abdu A, Aji SA. Outcome and complications of permanent hemodialysis vascular access in nigerians: a single centre experience. Ann Afr Med. 2013;12(2):127–30.CrossRefPubMed
44.
go back to reference Tannor EK, Chika OU, Okpechi IG. The impact of low socioeconomic status on progression of chronic kidney disease in low- and lower Middle-Income Countries. Semin Nephrol. 2022;42(5):151338.CrossRefPubMed Tannor EK, Chika OU, Okpechi IG. The impact of low socioeconomic status on progression of chronic kidney disease in low- and lower Middle-Income Countries. Semin Nephrol. 2022;42(5):151338.CrossRefPubMed
45.
go back to reference Crews DC, Bello AK, Saadi G, Li PKT, Garcia-Garcia G, Andreoli S, et al. Burden, Access, and disparities in kidney disease. Indian J Nephrol. 2019;29(2):77–83.CrossRefPubMedPubMedCentral Crews DC, Bello AK, Saadi G, Li PKT, Garcia-Garcia G, Andreoli S, et al. Burden, Access, and disparities in kidney disease. Indian J Nephrol. 2019;29(2):77–83.CrossRefPubMedPubMedCentral
46.
go back to reference Bello AK, Alrukhaimi M, Ashuntantang GE, Bellorin-Font E, Benghanem Gharbi M, Braam B et al. Global overview of health systems oversight and financing for kidney care. Kidney Int Suppl (2011). 2018;8(2):41–51. Bello AK, Alrukhaimi M, Ashuntantang GE, Bellorin-Font E, Benghanem Gharbi M, Braam B et al. Global overview of health systems oversight and financing for kidney care. Kidney Int Suppl (2011). 2018;8(2):41–51.
47.
go back to reference Mtingi-Nkonzombi L, Manning K, Du Toit T, Muller E, Redd AD, Freercks R. The state of kidney replacement therapy in Eastern Cape Province, South Africa: a call to action. S Afr Med J. 2023;113(4):e313.PubMed Mtingi-Nkonzombi L, Manning K, Du Toit T, Muller E, Redd AD, Freercks R. The state of kidney replacement therapy in Eastern Cape Province, South Africa: a call to action. S Afr Med J. 2023;113(4):e313.PubMed
48.
Metadata
Title
Global variations in funding and use of hemodialysis accesses: an international report using the ISN Global Kidney Health Atlas
Authors
Anukul Ghimire
Samveg Shah
Utkarsh Chauhan
Kwaifa Salihu Ibrahim
Kailash Jindal
Rumeyza Kazancioglu
Valerie A. Luyckx
Jennifer M. MacRae
Timothy O. Olanrewaju
Robert R. Quinn
Pietro Ravani
Nikhil Shah
Stephanie Thompson
Somkanya Tungsanga
Tushar Vachharanjani
Silvia Arruebo
Fergus J. Caskey
Sandrine Damster
Jo-Ann Donner
Vivekanand Jha
Adeera Levin
Charu Malik
Masaomi Nangaku
Syed Saad
Marcello Tonelli
Feng Ye
Ikechi G. Okpechi
Aminu K. Bello
David W. Johnson
Publication date
01-12-2024
Publisher
BioMed Central
Published in
BMC Nephrology / Issue 1/2024
Electronic ISSN: 1471-2369
DOI
https://doi.org/10.1186/s12882-024-03593-z

Other articles of this Issue 1/2024

BMC Nephrology 1/2024 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.